4/21/2010

Dutch researchers using PET and SPECT said the imaging methods allowed them to successfully and noninvasively visualize the insulinlike growth factor 1 receptor among animal subjects with triple-negative breast cancer. Being able to image the receptor could improve patient selection from the triple-negative breast cancer patient population for targeted treatment using IGF-1R antibodies, an expert said.

Related Summaries